| UCIS | Urothelial carcinoma in situ |
| BCG | Bacillus Calmette-Guérin |
| IHC | immunohistochemical |
| NGS | next generation sequencing |
| AMACR | Alpha-methylacyl-CoA racemase |
| PRAME | Preferentially Expressed Antigen in Melanoma |
| EV | enfortumab vedotin |
| ADC | antibody-drug conjugate |